Cargando…

A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions

INTRODUCTION: To integrate and execute a proper preventive plan and reduce the risk of non-communicable diseases (NCDs), policy makers need to have access to both reliable data and a unique definition of metabolic syndrome (MetS). This study was conducted on the data collected by cross-sectional stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabatabaei-Malazy, Ozra, Saeedi Moghaddam, Sahar, Rezaei, Nazila, Sheidaei, Ali, Hajipour, Mohammad Javad, Mahmoudi, Negar, Mahmoudi, Zohreh, Dilmaghani-Marand, Arezou, Rezaee, Kamyar, Sabooni, Mahdi, Razi, Farideh, Kompani, Farzad, Delavari, Alireza, Larijani, Bagher, Farzadfar, Farshad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928520/ https://www.ncbi.nlm.nih.gov/pubmed/33657130 http://dx.doi.org/10.1371/journal.pone.0241926

Ejemplares similares

Association between being metabolically healthy/unhealthy and metabolic syndrome in Iranian adults
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2022)

Trends of Diabetes Mortality in Iran at National and Sub-National Levels from 1990 to 2015 and Its Association with Socioeconomic Factors
por: Peykari, Niloofar, et al.
Publicado: (2022)

A year of experience with COVID‐19 in patients with cancer: A nationwide study
por: Khosravifar, Mina, et al.
Publicado: (2022)

Social determinants of health inequity in Iran: a narrative review
por: Rezaei, Negar, et al.
Publicado: (2022)

Editorial: Reducing the Burden of Age-Related Disease in Relation to Osteoporosis, Sarcopenia and Osteosarcopenia
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2022)

Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC–MS/MS technique
por: Hosseinkhani, Shaghayegh, et al.
Publicado: (2022)

Targeting metabolic disorders by natural products
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2015)

Beneficial Effects of Anti-Oxidative Herbal Medicines in Diabetic Patients Infected with COVID-19: A Hypothesis
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2020)

Evaluation of the diabetes care cascade and compliance with WHO global coverage targets in Iran based on STEPS survey 2021
por: Azadnajafabad, Sina, et al.
Publicado: (2023)

Trends of National and Subnational Incidence of Childhood Cancer Groups in Iran: 1990–2016
por: Shabani, Mahsima, et al.
Publicado: (2020)

Gender differences in association between metabolic syndrome and carotid intima media thickness
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2012)

Prevalence of Dyslipidemia in Iran: A Systematic Review and Meta-Analysis Study
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2014)

Twenty-Six-Year Trend of Mortality Rate Due to Ischemic Heart Diseases (IHDs) in Iran: 1990–2015
por: Naderimagham, Shohreh, et al.
Publicado: (2022)

Burden of tracheal, bronchus, and lung cancer in North Africa and Middle East countries, 1990 to 2019: Results from the GBD study 2019
por: Khanmohammadi, Shaghayegh, et al.
Publicado: (2023)

Trends in publication on evidence-based antioxidative herbal medicines in management of diabetic nephropathy
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2016)

New horizons in treatment of osteoporosis
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2017)

Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019
por: Nejadghaderi, Seyed Aria, et al.
Publicado: (2023)

A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017
por: Mohammadi, Esmaeil, et al.
Publicado: (2021)

National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019
por: Aryannejad, Armin, et al.
Publicado: (2023)

Correction to: National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019
por: Aryannejad, Armin, et al.
Publicado: (2023)

Scientometric study of academic publications on antioxidative herbal medicines in type 2 diabetes mellitus
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2016)

Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; Results from Global Burden of Disease study 2019
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2022)

Detection and Discrimination of Bacterial Colonies with Mueller Matrix Imaging
por: Badieyan, Saeedesadat, et al.
Publicado: (2018)

Hepatocellular carcinoma incidence at national and provincial levels in Iran from 2000 to 2016: A meta-regression analysis
por: Fattahi, Nima, et al.
Publicado: (2021)

Polymorphisms of Antioxidant Genes as a Target for Diabetes Management
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2017)

Scientometric analyzing the output of researchers and organizations on COVID-19 for better conducting the scientific efforts: with a glance to endocrinology
por: Atlasi, Rasha, et al.
Publicado: (2021)

A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017
por: Keykhaei, Mohammad, et al.
Publicado: (2021)

The association between acylcarnitine and amino acids profile and metabolic syndrome and its components in Iranian adults: Data from STEPs 2016
por: Taghizadeh, Hananeh, et al.
Publicado: (2023)

Scientometric assessment of scientific documents published in 2020 on herbal medicines used for COVID-19
por: Atlasi, Rasha, et al.
Publicado: (2022)

Scientometric Analysis of Global Scientific Publications on COVID-19 and Diabetes with an Emphasis on Middle Eastern Countries
por: Atlasi, Rasha, et al.
Publicado: (2022)

The association of carotid intima media thickness with retinol binding protein-4 and total and high molecular weight adiponectin in type 2 diabetic patients
por: Mansouri, Masoumeh, et al.
Publicado: (2012)

Effect of metabolic control on oxidative stress, subclinical atherosclerosis and peripheral artery disease in diabetic patients
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2015)

Obesity Researches Over the Past 24 years: A Scientometrics Study in Middle East Countries
por: Djalalinia, Shirin, et al.
Publicado: (2015)

Non-communicable Diseases and COVID-19; a double-edged sword A Special Communication from IRAN
por: Peykari, Niloofar, et al.
Publicado: (2020)

Mortality Attributable to Excess Body Mass Index in Iran: Implementation of the Comparative Risk Assessment Methodology
por: Djalalinia, Shirin, et al.
Publicado: (2015)

High Fasting Plasma Glucose Mortality Effect: A Comparative Risk Assessment in 25–64 Years Old Iranian Population
por: Peykari, Niloofar, et al.
Publicado: (2016)

Burden of thyroid cancer in North Africa and Middle East 1990–2019
por: Nejadghaderi, Seyed Aria, et al.
Publicado: (2022)

Who are diabetic foot patients? A descriptive study on 873 patients
por: Madanchi, Nima, et al.
Publicado: (2013)

Characteristics of published/registered clinical trials on COVID-19 treatment: A systematic review
por: Asili, Pooria, et al.
Publicado: (2021)

Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019
por: Moradi, Soroush, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e3db5pvcal7vhpunqep1fhs2ar